ClinicalMetric / Countries / Japan / pancreatic ductal adenocarcinoma
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

pancreatic ductal adenocarcinoma Clinical Trials in Japan

Active clinical trials for pancreatic ductal adenocarcinoma with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 1 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT07094204 Phase 1
Recruiting

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Enrollment
364 pts
Country
🇯🇵 Japan
Astellas Pharma Inc
View Trial →

Frequently Asked Questions

How many pancreatic ductal adenocarcinoma clinical trials are active in Japan?
There are currently 1 active clinical trials for pancreatic ductal adenocarcinoma with sites in Japan, of which 1 are actively recruiting patients.
How can I join a pancreatic ductal adenocarcinoma clinical trial in Japan?
To join a pancreatic ductal adenocarcinoma clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic ductal adenocarcinoma trials in Japan?
Active pancreatic ductal adenocarcinoma trials in Japan span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global pancreatic ductal adenocarcinoma Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology